Cargando…

Related donor platelet transfusion improves platelet transfusion refractoriness in hematological patients

OBJECTIVE: Transfusion of HLA-matched platelets can reduce the effect of alloimmune responses on platelet transfusion efficacy; however, finding HLA-matched platelets in the population is nearly impossible. Almost all HLA-matched platelets from related are half-matched, but the hemostatic efficacy o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing-Cheng, Ni, Li-Hong, Tu, Yan, Hu, Hui-Xian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014593/ https://www.ncbi.nlm.nih.gov/pubmed/36936203 http://dx.doi.org/10.3389/fmed.2023.983644

Ejemplares similares

Refractoriness to platelet transfusion after single-donor consecutive platelet transfusions and its relationship to platelet antibodies.
por: Lee, M., et al.
Publicado: (1988)

Evaluation and management of platelet transfusion refractoriness
por: Youk, Hee-Jeong, et al.
Publicado: (2022)

The Non-Hemostatic Aspects of Transfused Platelets
por: Sut, Caroline, et al.
Publicado: (2018)

Prevalence of platelet reactive antibodies in patient's refractory to platelet transfusions
por: Agarwal, Nitin, et al.
Publicado: (2014)

Evaluation of Human Leucocyte Antigen Mediated Platelet Transfusion Refractoriness and Platelet Crossmatching Assay in Patients with Hematologic Disorders
por: Neanaey, Wafaa A., et al.
Publicado: (2022)

Toward the Relevance of Platelet Subpopulations for Transfusion Medicine
por: Handtke, Stefan, et al.
Publicado: (2018)

Routine Screening Method for Microparticles in Platelet Transfusions
por: Millar, Daniel, et al.
Publicado: (2018)

Current Status of and Global Trends in Platelet Transfusion Refractoriness From 2004 to 2021: A Bibliometric Analysis
por: Liu, Ying, et al.
Publicado: (2022)

Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion
por: Belizaire, Roger, et al.
Publicado: (2020)

Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019)

PB2596: OPTIMIZING PLATELET TRANSFUSION FOR CLINICAL PRACTICE. DO PLATELETS AGE MATTER FOR THERAPEUTIC PLATELETS TRANSFUSION?
por: Attallah, Samy, et al.
Publicado: (2023)

Neonatal thrombocytopenia and platelets transfusion
por: Gupta, Anil K., et al.
Publicado: (2012)

Current concepts in platelet transfusion
por: Mohanty, Dipika
Publicado: (2009)

Blood and platelet transfusion from a donor with presymptomatic Covid-19
por: Liapis, Konstantinos, et al.
Publicado: (2020)

Transfusion‐induced platelet antibodies and regulatory T cells in multiply transfused patients
por: Song, Tiejun, et al.
Publicado: (2021)

First platelet transfusion refractoriness in a patient with acute myelocytic leukemia: A case report
por: Tu, Sheng-Ke, et al.
Publicado: (2023)

Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia
por: Hu, Xuelian, et al.
Publicado: (2020)

Platelets: Production, Function, Transfusion, and Storage
por: Marchesi, Sally L.
Publicado: (1975)

Thrombocytopenia in leptospirosis and role of platelet transfusion
por: Sharma, Jayashree, et al.
Publicado: (2007)

Platelet Transfusion: And Update on Challenges and Outcomes
por: Solves Alcaina, Pilar
Publicado: (2020)

Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021)

Applicability of an instrument to identify human leukocyte antigen-compatible donors for platelet transfusions
por: Ferreira, Millena Gomes, et al.
Publicado: (2018)

Platelet transfusion for cancer secondary thrombocytopenia: Platelet and cancer cell interaction
por: Wang, Juan, et al.
Publicado: (2021)

Redox Proteomics and Platelet Activation: Understanding the Redox Proteome to Improve Platelet Quality for Transfusion
por: Sonego, Giona, et al.
Publicado: (2017)

Extent of transfusion support in a developing country in managing a bleeding acute myeloid leukemia patient with platelet transfusion refractoriness
por: Chellaiya, Gayathiri K., et al.
Publicado: (2021)

Genetic platelet depletion is superior in platelet transfusion compared to current models
por: Salzmann, Manuel, et al.
Publicado: (2020)

Genetic platelet depletion is superior in platelet transfusion compared to current models
por: Salzmann, Manuel, et al.
Publicado: (2020)

Consensus conference on platelet transfusion: final statement.
Publicado: (1998)

Platelet transfusions: trigger, dose, benefits, and risks
por: Blumberg, Neil, et al.
Publicado: (2010)

Platelet Transfusion – The New Immunology of an Old Therapy
por: Stolla, Moritz, et al.
Publicado: (2015)

Bacterial contamination of platelets for transfusion: strategies for prevention
por: Levy, Jerrold H., et al.
Publicado: (2018)

New Emerging Developments of Platelets in Transfusion Medicine
por: Stolla, Moritz, et al.
Publicado: (2020)

Transfusion Triggers for Platelets and Other Blood Products
por: Karanth, Sunil
Publicado: (2019)

Impact of platelet transfusion on outcomes in trauma patients
por: Hamada, S. R., et al.
Publicado: (2022)

Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice
por: Couvidou, Adèle, et al.
Publicado: (2022)

Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019)

Changes in inflammatory responses and autophagy during apheresis platelet preservation and their correlation with platelet transfusion refractoriness in patients with acute lymphoblastic leukemia
por: Li, Ying, et al.
Publicado: (2023)

Rapid decreasing of transfused platelet in a cancerous patient: Anti-platelet antibody
por: Joob, Beuy, et al.
Publicado: (2012)

The Signaling Role of CD40 Ligand in Platelet Biology and in Platelet Component Transfusion
por: Aoui, Chaker, et al.
Publicado: (2014)

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ec2mnga4bcnqa7a4qrbjs983uv